SAN DIEGO, Aug. 11, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its vice president of investor relations will be speaking at the following investor conference:
- UBS MedTech, Tools and Genomics Summit 2023 on August 17, 2023
Fireside chat at 9:00am Pacific Time (12:00pm Eastern Time)
The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. In 2023, we celebrate 25 years of innovation, which has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok and YouTube.
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
David McAlpine
+1.347.327.1336
pr@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conference-301899042.html
SOURCE Illumina, Inc.
